Can the Zantac recall save others from... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Zantac wasn’t the first ranitidine drug to... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Food and Drug Administration expands NDMA testing... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 21, 2026 Read More
What NDMA is and what overexposure looks... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 27, 2026 Read More
Do you need some clarification of the... By James L. Ferraro | Zantac Recall | Last Modified on Feb 20, 2026 Read More
Did the FDA miss the potential harm... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 23, 2026 Read More
If you were a 9/11 responder in... By James L. Ferraro | Asbestos Exposure & Claims | Last Modified on Feb 20, 2026 Read More
Food and Drug Administration issues recall of... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 27, 2026 Read More
Failure to yield leads to numerous vehicle... By James L. Ferraro | Car Accidents | Last Modified on Feb 21, 2026 Read More
Asbestos exposure could result from siding on... By James L. Ferraro | Asbestos Exposure & Claims | Last Modified on Feb 20, 2026 Read More
Distracted driving plays a role in too... By James L. Ferraro | Car Accidents | Last Modified on Feb 27, 2026 Read More
Hazardous materials found in yet another food... By James L. Ferraro | Products Liability | Last Modified on Feb 20, 2026 Read More